Integra Lifesciences (NASDAQ: IART) and NuVasive (NASDAQ:NUVA) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability.
This is a breakdown of current ratings and recommmendations for Integra Lifesciences and NuVasive, as provided by MarketBeat.com.
||Strong Buy Ratings
Integra Lifesciences presently has a consensus target price of $51.88, indicating a potential upside of 2.58%. NuVasive has a consensus target price of $71.64, indicating a potential upside of 34.34%. Given NuVasive’s stronger consensus rating and higher probable upside, analysts clearly believe NuVasive is more favorable than Integra Lifesciences.
Insider & Institutional Ownership
87.6% of Integra Lifesciences shares are owned by institutional investors. 21.5% of Integra Lifesciences shares are owned by insiders. Comparatively, 1.2% of NuVasive shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
This table compares Integra Lifesciences and NuVasive’s net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Valuation and Earnings
This table compares Integra Lifesciences and NuVasive’s revenue, earnings per share (EPS) and valuation.
||Earnings Per Share
Integra Lifesciences has higher revenue and earnings than NuVasive. NuVasive is trading at a lower price-to-earnings ratio than Integra Lifesciences, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Integra Lifesciences has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500. Comparatively, NuVasive has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500.
Integra Lifesciences beats NuVasive on 8 of the 14 factors compared between the two stocks.
Integra Lifesciences Company Profile
Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.
NuVasive Company Profile
Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.
Receive News & Ratings for Integra Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.